Page last updated: 2024-11-12

metamelfalan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11098767
CHEMBL ID2107075
SCHEMBL ID2015275
MeSH IDM0151758

Synonyms (27)

Synonym
m-l-sarcolysin
3-(m-(bis(2-chloroethyl)amino)phenyl)-l-alanine
metamelfalan [inn:ban]
(s)-3-(3-(bis-(2-chlorethyl)amino)phenyl)-2-aminopropionsaeure
3-(bis(2-chloroethyl)amino)-l-phenylalanine
nsc 67781
metamelfalan
metamelfalanum [inn-latin]
l-3-(m-(bis(2-chloroethyl)amino)phenyl)alanine
alanine, 3-(m-(bis(2-chloroethyl)amino)phenyl)-, l-
l-phenylalanine, 3-(bis(2-chloroethyl)amino)-
l-m-sarcolysin
1088-80-8
nsc-67781
metamelfalanum
unii-3b30xbe7s2
3b30xbe7s2 ,
CHEMBL2107075
metamelfalan [who-dd]
metamelfalan [inn]
SCHEMBL2015275
m-[di(2-chloroethyl)amino]-l-phenylalanine
DTXSID50883183
(s)-2-amino-3-(3-(bis(2-chloroethyl)amino)phenyl)propanoic acid
(2s)-2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid
Q27256990
AKOS040746103

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" One of the peptides, L-propyl-m-sarcolysyl-L-p-fluorophenylalanine (PSF), is highly toxic to melanoma cells."( Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
Hansson, J; Lewensohn, R; Ringborg, U,
)
0.13
" In a previous investigation we found that Peptichemio was less toxic to human lymphoblasts than m-L-sarcolysin."( Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
Ehrsson, H; Hansson, J; Lewensohn, R; Ringborg, U,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409953Inhibition of mouse liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409955Inhibition of mouse liver MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.46 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]